The University of Maryland BioPark-based company moved to Baltimore in 2017. Now it’s looking to continue growing a team as it moves its device to market. Published 2/10/20 on Technical.ly Baltimore Two years ago, ARMR Systems moved to Baltimore to base development …
Published 2/11/20 on UMIACS, University of Maryland, College Park Website A noted Baltimore philanthropic organization has awarded a $50,000 grant to the Maryland Blended Reality Center (MBRC) in support of using new immersive technologies for education, humanitarian purposes and social change. The …
January 31, 2020 — The opportunistic bacterial pathogen, Clostridioides difficile, is the leading cause of hospital-acquired infection in the US, afflicting 500,000 individuals and causing an estimated 15,000 deaths each year. In addition to the challenge of drug-resistant infections, many C. difficile symptoms are …
IBBR researchers receive funding to explore the use of viral proteins against the bacteria that cause acne (Rockville, MD, February 4, 2020) Over 80% of adolescents and an increasing number of adults are affected by acne vulgaris—commonly known as “acne”—a …
Published 1/31/20 on Maryland Today Winter Class Gets ‘Chilling’ In-Person View of Daily Life on U.S.-Mexico Border UMD students stand near a fence separating the U.S. and Mexico in the Rio Grande Valley as part of a winter MLaw Programs …
UMCP, UMB Roll Out Achievements in Annapolis Showcase Published 1/21/20 on Maryland Today Research powerhouses on their own, the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) have a combined effect that’s greater still, tackling pressing …
Jan. 21, 2020 Dear Colleagues: We are delighted to announce that the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) have further formalized our strategic partnership, which unifies our research activities as a single enterprise. …
Published 12/11/19 on Tech Transfer eNews Blog A start-up from the University of Maryland-Baltimore (UMB) is advancing a treatment for inflammatory and age-related diseases. GEn1E Lifesciences is based on a p38a kinase inhibitor program developed at UMB. The start-up aims …
Published 12/3/19 on PRNewswire PALO ALTO, Calif. and BALTIMORE, Dec. 3, 2019 /PRNewswire/ — GEn1E Lifesciences Inc., a Y Combinator-backed biotech startup focused on curing inflammatory and age-related diseases, announced today that it has acquired an exclusive, worldwide and all-fields license to the University of …
Published 11/26/19 on UMB News Keith Ohlinger, 50, owner of Porch View Farm in Howard County, got straight to the point. “Farming is hard work,” he told the sold-out crowd at the fifth annual Agricultural and Environmental Law Conference held …